Compare CGEN & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | SEVN |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 167.9M |
| IPO Year | 2001 | 2008 |
| Metric | CGEN | SEVN |
|---|---|---|
| Price | $1.99 | $6.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $4.60 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 232.4K | 190.3K |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 17.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | N/A | $15.62 |
| P/E Ratio | ★ N/A | $12.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.43 | $5.98 |
| 52 Week High | $3.24 | $9.81 |
| Indicator | CGEN | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 48.06 |
| Support Level | $1.98 | $5.98 |
| Resistance Level | $2.37 | $8.84 |
| Average True Range (ATR) | 0.10 | 0.22 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 36.36 | 60.75 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.